J. Bartroli et al., SYNTHESIS AND ANTIFUNGAL ACTIVITY OF NEW AZOLE DERIVATIVES CONTAININGAN N-ACYLMORPHOLINE RING, Journal of medicinal chemistry, 38(20), 1995, pp. 3918-3932
A series of azole derivatives carrying an N-acylmorpholine ring are de
scribed. The compounds were chemically designed to simulate the lanost
erol D ring, taking advantage of the conformational preferences of 2-a
lkyl-1-acylmorpholines. Three structural variables, the nature of the
N-benzoyl group, the phenyl substituents, and the degree of oxidation
at carbon 2 of the morpholine, were optimized for maximum activity. On
ly the (5R,6R) isomers showed antifungal activity. Cyclic hemiacetal(-
)-39a (UR-9746) and cyclic ether (-)-41 (UR-9751) were selected for fu
rther development. In vitro, (-)-41 was clearly more active than (-)-3
9a and somewhat less active than the acyclic counterpart (-)-7. lit vi
vo activity was assessed by a systemic (mouse) and a vaginal (rat) can
didosis model. In the former, (-)-39a, (-)-41, and (-)-7 at 1 mg/kg gi
ven 1, 4, and 24 h postinfection displayed 90-100% protection from mor
tality on day 9. Compound (-)-39a was slightly more potent than (-)-41
and similar in potency to (-)-7. The three compounds were superior in
potency to fluconazole and similar in potency to SCH-42427 in this te
st. In the vaginal model, (-)-39a and (-)-41 given daily during 3 days
after infection at 0.5 mg/kg showed high levels of protection on days
10 and 15. At 0.25 mg/kg, (-)-39a was slightly more potent than SCH-4
2427 and (-)-7 and superior in potency to (-)-41 and fluconazole in th
is model. Preliminary 28-day toxicity tests at 100 mg/kg/day po in rat
s indicated no or very mild adverse effects for the two UR compounds.